Cancer Channel
Topics
Medications
Quicklinks
Related Channels

Ontak Medication Information

Adults who have cutaneous T-cell lymphoma that has not improved or has returned after trying other treatments may benefit from a medication called Ontak® (denileukin diftitox). This medicine is only used when a certain protein is present on the surface of the cancer cells. Ontak binds to these particular proteins and then releases a type of toxin that causes the cancer cells to die.
 
Ontak comes as a liquid that is given slowly into a vein using an intravenous (IV) infusion. A healthcare provider will administer the medicine for five days in a row, once every three weeks. This regimen is repeated for eight cycles, unless serious side effects occur.
 
Before starting treatment with Ontak, it is important to review the medication's safety warnings with your healthcare provider. This includes information on potential side effects, drug interactions, and other precautions to ensure this form of chemotherapy treatment is appropriate for you.
 
(Click Ontak for more information on this medication, including possible side effects, details on who should not use this drug, and dosing guidelines.)
 

Ontak Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.